CSIQ · Canadian Solar Inc.

The thesis

Canadian Solar's recovery case remains unproven, and the shares have weakened further: the adjusted close was $9.22 on 22 October 2026, 72.5% below the 52-week high of $33.58. The third-quarter 2026 report, expected around 13 November 2026 (unconfirmed by the company), settles it by showing whether revenue clears the $1.3 billion guidance floor and whether U.S. module contract prices rose.

The narrative is dead on the price test: the shares closed below the $10.50 daily level and the $10.80 close of 25 September 2026 that the 10 October 2026 note set as the recent low. They fell 33.1% over three months, and the 14-day relative strength index (a 0–100 momentum gauge) was 29.3 on 22 October 2026.

Two analyst moves arrived after the last note. JPMorgan maintained its Underweight rating and lowered its target to $8 on 19 October 2026. UBS maintained Buy and lowered its target to $16 on 14 October 2026. The gap between the two targets is wide, and both are below where analysts stood earlier in the year.

Bullish and bearish views on Canadian Solar Inc.

The bull case on Canadian Solar Inc. (CSIQ), in brief: Contract terms permit an adjustment. The bear case: The price broke its prior floor.

Bull case

• Contract terms permit an adjustment. On 27 August 2026, management said its U.S. module contracts carry change-in-law mechanisms and that the reported backlog, more than 13 gigawatts worth over $4.5 billion through 2029, excluded any Section 232 (a U.S. trade-law tariff authority) adjustment. A disclosed price increase would turn that from a possibility into a result.
• Storage deliveries beat guidance. Second-quarter storage shipments were 3.7 gigawatt-hours against guidance of 2.8–3.2 gigawatt-hours, per the 27 August 2026 results. On 6 October 2026 the company announced a 100 megawatt / 200 megawatt-hour battery supply and commissioning agreement for OX2's Muswellbrook solar farm in Australia.
• Project pipeline is reaching operation. On 15 October 2026, Recurrent Energy, the company's project developer, began commercial operations at the Villameca solar portfolio in Castilla y León, Spain.
• A sell-side buyer remains. UBS kept a Buy rating on 14 October 2026 while lowering its target to $16, still well above the $9.22 close.

Bear case

• The price broke its prior floor. The close of $9.22 on 22 October 2026 sits below the 25 September 2026 close of $10.80 and the $10.50 invalidation level of the 10 October 2026 note. Shares fell 33.1% over three months.
• Analysts are cutting targets. JPMorgan lowered its target to $8 with an Underweight rating on 19 October 2026, and UBS cut to $16 five days earlier. Both reductions came within the last ten days.
• Profitability is weak. Second-quarter 2026 gross margin was 13.9% and the attributable net loss was $77 million, per the 27 August 2026 results. Management said Jeffersonville ramp costs would weigh on profitability for the rest of 2026.
• Manufacturing milestone is unconfirmed. Management targeted full-scale production at the Jeffersonville, Indiana Phase I cell plant (2.1 gigawatts) for 1 October 2026. Searches of company news through 22 October 2026 found no announcement confirming it.

Price setup

The adjusted close was $9.22 on 22 October 2026, against a 52-week high of $33.58. The 14-day relative strength index of 29.3 is near the 30 level conventionally read as oversold, down from 45.2 on 9 October 2026.

The $10.80 close of 25 September 2026 and the $12.00 weekly level are now overhead. JPMorgan's $8 target is the nearest analyst-defined level below the shares.

Crowding evidence is thin. The shares fell 33.1% over three months, there is no wide gap above a rising moving average, and no filing or news since 9 October 2026 shows insider selling or share issuance. As a foreign private issuer, Canadian Solar does not file U.S. Form 4 insider reports, so that screen is incomplete. The next earnings report is the only imminent event.

Catalysts, next 30 days

• ~13 November 2026 (est.) — Third-quarter 2026 report and call. The company has not confirmed the date. The report tests guidance of $1.3–1.5 billion revenue and 13.5–15.5% gross margin, plus any disclosed Section 232 price adjustments.

Elapsed catalysts

• 31 October 2026 — Jeffersonville plant update. Management targeted full-scale Phase I production for 1 October 2026 and no confirmation has been reported. A confirmed start supports the domestic-supply case; a delay removes the nearest manufacturing proof point. (passed 6d ago)

What would change the view

The case breaks if third-quarter 2026 revenue comes in at or below the $1.3 billion floor, if gross margin falls under 13.5%, or if the company reports unchanged prices on existing U.S. module contracts. A reported miss on the Jeffersonville Phase I start would add to that.

On price, a daily close below $8.50 would put the shares under JPMorgan's $8 target zone and confirm continued selling. The case improves only if the company discloses higher domestic-module prices and revenue above $1.3 billion, with a weekly close back above $12.00.

What it trades with

Canadian Solar trades with U.S. solar module and storage names on tariff and trade-policy news, since its backlog value depends on the Section 232 outcome. Recurrent Energy project-sale timing can move quarterly results independently of module shipments, as the 27 August 2026 deferral showed. Interest-rate moves affect project financing and solar equities broadly.